Do patient preferences for core outcome domains for chronic gout studies support the validity of composite response criteria?

Arthritis Care and Research

Volumn 65, Issue 8, 2013, Pages 1259-1264

  Taylor, William J ^a   Brown, Melanie ^a   Aati, Opetaia ^b   Weatherall, Mark ^a   Dalbeth, Nicola ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

URATE;

ADULT; AGED; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CLINICAL STUDY; FEMALE; GOUT; HUMAN; MALE; OUTCOME ASSESSMENT; PATIENT DECISION MAKING; PATIENT PREFERENCE; PHYSICAL DISABILITY; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL; VALIDITY;

AGED; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; FEMALE; GOUT; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT PREFERENCE; REPRODUCIBILITY OF RESULTS;

EID: 84881332278     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21955     Document Type: Article

References (20)

1. Anderson JJ,. Mean changes versus dichotomous definitions of improvement. Stat Methods Med Res 2007; 16: 7-12.
2. Schlesinger N, Dalbeth N, Perez, Ruiz F,. Gout: what are the treatment options? Expert Opin Pharmacother 2009; 10: 1319-28.
3. Schumacher HR Jr, Taylor W, Edwards NL, Grainger R, Schlesinger N, Dalbeth N, et al. Outcome domains for studies of acute and chronic gout. J Rheumatol 2009; 36: 2342-5.
4. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995; 38: 727-35.
5. Gladman DD, Tom BD, Mease PJ, Farewell VT,. Informing response criteria for psoriatic arthritis. I. Discrimination models based on data from 3 anti-tumor necrosis factor randomized studies. J Rheumatol 2010; 37: 1892-7.
6. Gladman DD, Landewe R, McHugh NJ, Fitzgerald O, Thaci D, Coates L, et al. Composite measures in psoriatic arthritis: GRAPPA 2008. J Rheumatol 2010; 37: 453-61.
7. Pham T, van der Heijde D, Lassere M, Altman RD, Anderson JJ, Bellamy N, et al. Outcome variables for osteoarthritis clinical trials: the OMERACT-OARSI set of responder criteria. J Rheumatol 2003; 30: 1648-54.
8. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M,. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001; 44: 1876-86.
9. Van Tubergen A, van der Heijde D, Anderson J, Landewe R, Dougados M, Braun J, et al. Comparison of statistically derived ASAS improvement criteria for ankylosing spondylitis with clinically relevant improvement according to an expert panel. Ann Rheum Dis 2003; 62: 215-21.
10. Cordoba G, Schwartz L, Woloshin S, Bae H, Gotzsche PC,. Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review. BMJ 2010; 341: c3920.
11. Montori VM, Permanyer-Miralda G, Ferreira-Gonzalez I, Busse JW, Pacheco-Huergo V, Bryant D, et al. Validity of composite end points in clinical trials. BMJ 2005; 330: 594-6.
12. International Society on Multiple Criteria Decision Making. 2010. URL: http://www.mcdmsociety.org/intro.html.
13. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum 2010; 62: 2582-91.
14. Transport Analysis Guidance; WebTAG. 2010. URL: http://www.dft.gov.uk/ webtag/.
15. Hadorn DC, Holmes AC,. The New Zealand priority criteria project. Part 1: overview. BMJ 1997; 314: 131-4.
16. Hansen P, Ombler F,. A new method for scoring additive multi-attribute value models using pairwise rankings of alternatives. J Multi-Crit Decis Anal 2009; 15: 87-107.
17. Van Tuyl LH, Boers M,. Patient's global assessment of disease activity: what are we measuring? [editorial]. Arthritis Rheum 2012; 64: 2811-3.
18. Felson DT, Anderson JJ, Meenan RF,. Time for changes in the design, analysis, and reporting of rheumatoid arthritis clinical trials. Arthritis Rheum 1990; 33: 140-9.
19. Tilley BC, Pillemer SR, Heyse SP, Li S, Clegg DO, Alarcon GS, for the MIRA Trial Group. Global statistical tests for comparing multiple outcomes in rheumatoid arthritis trials. Arthritis Rheum 1999; 42: 1879-88.
20. Bartolucci AA, Singh KP,. Multiple testing in a rheumatoid arthritis trial: statistical comparison of two therapies with respect to several end points. Arthritis Care Res 1992; 5: 70-3.